Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-21, Stock:JNJ, The news for the past five days is as follows:
2019-02-13: NEWS1: Johnson & Johnson supplier seeks bankruptcy over talc lawsuits.NEWS2: Imerys Talc Units File Bankruptcy as Cancer-Suit Risk Soars.NEWS3: [$$] Johnson & Johnson Talc Supplier Files for Bankruptcy.NEWS4: Johnson & Johnson supplier seeks bankruptcy over talc lawsuits.NEWS5: Here Is What&apos;s Surprising About J&J&apos;s Robotic Surgery Buyout.NEWS6: Dow Ends Off Highs but Optimism Remains Over a U.S.-China Trade Deal.NEWS7: Stocks rise as Trump signals China trade flexibility.NEWS8: The Funded: 9 Bay Area startups raising nearly $900M at midweek.NEWS9: Why Geron Stock Briefly Spiked Today.NEWS10: Why Geron Stock Briefly Spiked Today.NEWS11: Dow Jones Today: J&J Buys Robotics Firm; Cisco Systems Falls Ahead Of Earnings.NEWS12: Imerys Talc America files for bankruptcy under weight of talc litigation.NEWS13: Traders boost the wrong stock for a second time after J&J takeover.NEWS14: Traders boost the wrong stock for a second time after J&J takeover.NEWS15: Dow Comes Off Highs but Optimism Remains Over a U.S.-China Trade Deal.NEWS16: Imerys Talc America to file for Chapter 11 bankruptcy - statement.NEWS17: Johnson & Johnson to Buy Robotic Surgery Company Auris Health for $3.4 Billion.NEWS18: Why Geron Stock Briefly Spiked Today.NEWS19: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS20: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS21: Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS.NEWS22: Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS.NEWS23: Johnson & Johnson to buy surgical robotics firm Auris for $3.4 billion.NEWS24: Johnson & Johnson delves into robotics, buys Auris Health for $3.4 billion.NEWS25: Johnson & Johnson to pay $3.4B to buy Auris Health.NEWS26: Case of Mistaken Identity Sends Auris Medical Shares Soaring 30%.NEWS27: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS28: Johnson & Johnson Makes $3.4 Billion Buy Into Robotic Surgery Field.NEWS29: Stocks Extend Rally as Trade Optimism Buoys Wall Street.NEWS30: Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits.NEWS31: Health Care Sector Update for 02/13/2019: BABY, TEVA, EXEL, JNJ, PFE, ABT, MRK, AMGN.NEWS32: Health Care Sector Update for 02/13/2019: BABY, TEVA, EXEL, JNJ, PFE, ABT, MRK, AMGN.NEWS33: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS34: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS35: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 14, 2019.NEWS36: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 14, 2019.NEWS37: Johnson & Johnson will acquire surgical robotics company Auris Health.NEWS38: Johnson & Johnson to buy Auris Health for $3.4 billion.NEWS39: Johnson & Johnson to buy Auris Health for $3.4 billion.NEWS40: Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc..NEWS41: The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering.NEWS42: PRESS DIGEST-New York Times business news - Feb 13.NEWS43: [$$] Johnson & Johnson to buy robotics group Auris Health for $3.4bn.
2019-02-14: NEWS1: Is Johnson & Johnson CEO Alex Gorsky Earning His Pay?.NEWS2: Is Johnson & Johnson CEO Alex Gorsky Earning His Pay?.NEWS3: Veracyte CEO navigated early troubles, now has her company on path to growth.NEWS4: Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B.NEWS5: Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B.NEWS6: Bayer stresses drug's tolerability in bid for prostate cancer market.NEWS7: Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B.NEWS8: 10 Hot Stocks Leading the Market’s Blitz Higher.NEWS9: Is Johnson & Johnson CEO Alex Gorsky Earning His Pay?.NEWS10: Veracyte CEO navigated early troubles, now has her company on path to growth.NEWS11: FDA Panel Nod for J&J's Esketamine Is Good News for Allergan, Vistagen.NEWS12: Johnson & Johnson to Participate in the 8th Annual SVB Leerink Global Healthcare Conference.NEWS13: Did Johnson & Johnson Just Spit in Alphabet's Face?.NEWS14: Did Johnson & Johnson Just Spit in Alphabet's Face?.NEWS15: Health Care Sector Update for 02/14/2019: MTFB, MDGS, INO, JNJ, PFE, MRK, ABT, AMGN.NEWS16: Health Care Sector Update for 02/14/2019: MTFB, MDGS, INO, JNJ, PFE, MRK, ABT, AMGN.NEWS17: Did Johnson & Johnson Just Spit in Alphabet&apos;s Face?.NEWS18: [$$] J&J and Novartis back cancer geneticist’s immunotherapy start-up.NEWS19: [$$] Johnson & Johnson to Buy Surgical Robotics Maker.
2019-02-15: NEWS1: Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'.NEWS2: Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson.NEWS3: The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings.NEWS4: This Is One Company That Could Break Up Bristol-Celgene Deal.NEWS5: Here&apos;s The Dark Horse Contender That Could Break Up Bristol-Celgene.NEWS6: Health Care Sector Update for 02/15/2019: AKAO, ORPN, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 02/15/2019: AKAO, ORPN, CGC, JNJ, PFE, ABT, MRK, AMGN.
2019-02-19: NEWS1: New Road Rules for This Market: Cramer's 'Mad Money' Recap (Tues. 2/19/19).NEWS2: GM, Bank of America and Johnson & Johnson earn top scores in new study of corporate gender equality.NEWS3: The Charts of Johnson & Johnson Do Not Yet Convince Me of the Bull Case.NEWS4: Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN.
2019-02-20: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: How this Bay Area telemedicine startup is bringing second opinions to patients from Boise to Beijing.NEWS3: Lake Nona's growth, 'financial strength' lure HQ relocations.NEWS4: Johnson & Johnson Acquisition Fuels Deal Speculation in Surgical Robotics.NEWS5: Health Care Sector Update for 02/20/2019: ACET, OMI, FMS, NXTM, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 02/20/2019: ACET, OMI, FMS, NXTM, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Nasal spray developed by Johnson & Johnson may be the key to fighting treatment resistant depression.

Answer: Decrease